Mediastinal lymphadenopathy: A serious complication in COVID-19 patients.
作者信息
Khatri Govinda, Saleem Minahil Binte, Kumar Ayush, Hasan Mohammad Mehedi
机构信息
Dow University of Health Sciences, Karachi, Pakistan.
Aga Khan University Hospital, Karachi, Pakistan.
出版信息
Ann Med Surg (Lond). 2022 Jul;79:104039. doi: 10.1016/j.amsu.2022.104039. Epub 2022 Jun 20.
Abstract
摘要
相似文献
1
Mediastinal lymphadenopathy: A serious complication in COVID-19 patients.纵隔淋巴结肿大：新冠病毒感染患者的一种严重并发症。
Ann Med Surg (Lond). 2022 Jul;79:104039. doi: 10.1016/j.amsu.2022.104039. Epub 2022 Jun 20.
2
CT Characteristics of Coronavirus Disease 2019 Pneumonia and Its Association with C-Reactive Protein, Erythrocyte Sedimentation Rate and Gender.2019冠状病毒病肺炎的CT特征及其与C反应蛋白、红细胞沉降率和性别的关系
Adv Biomed Res. 2022 Jan 31;11:10. doi: 10.4103/abr.abr_33_21. eCollection 2022.
3
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染：综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
4
Mediastinal Lymphadenopathy As A Predictor Of Worse Outcome In Severe Covid-19 Cases.纵隔淋巴结病是重症 COVID-19 病例预后不良的预测因素。
J Ayub Med Coll Abbottabad. 2022 Apr-Jun;34(2):321-325. doi: 10.55519/JAMC-02-9469.
5
C-reactive protein, D-dimer, erythrocyte sedimentation rate, and troponin in intensive care unit patients with COVID-19 in Iran.伊朗新冠肺炎重症监护病房患者的C反应蛋白、D-二聚体、红细胞沉降率和肌钙蛋白
J Res Med Sci. 2023 Jun 28;28:56. doi: 10.4103/jrms.jrms_352_22. eCollection 2023.
6
Mediastinal lymphadenopathy and prognosis of COVID-19 disease.纵隔淋巴结肿大与新型冠状病毒肺炎疾病的预后
Iran J Microbiol. 2021 Aug;13(4):495-501. doi: 10.18502/ijm.v13i4.6974.
7
Severe Coronavirus disease 2019 pneumonia patients showed signs of aggravated renal impairment.严重的 2019 冠状病毒病肺炎患者表现出肾功能损害加重的迹象。
J Clin Lab Anal. 2020 Oct;34(10):e23535. doi: 10.1002/jcla.23535. Epub 2020 Aug 25.
8
Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.巴西原住民中由严重急性呼吸综合征冠状病毒2感染或其他病原体引起的严重急性呼吸综合征：一项关于冠状病毒病（COVID）-19大流行第一年的观察性研究。
Lancet Reg Health Am. 2022 Apr;8:100177. doi: 10.1016/j.lana.2021.100177. Epub 2022 Jan 7.
9
Effect of curcumin-pipeine supplementation on clinical status, mortality rate, oxidative stress, and inflammatory markers in critically ill ICU patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.姜黄素-胡椒碱补充剂对 COVID-19 重症 ICU 患者临床状况、死亡率、氧化应激和炎症标志物的影响：一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jul 6;22(1):434. doi: 10.1186/s13063-021-05372-9.
10
Spectrum of neurologic & neuroimaging manifestation in COVID-19.新型冠状病毒肺炎的神经及神经影像学表现谱
Brain Behav Immun Health. 2021 May;13:100238. doi: 10.1016/j.bbih.2021.100238. Epub 2021 Mar 3.
引用本文的文献
1
Hematopathology of Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Coronavirus Disease-19.严重急性呼吸综合征冠状病毒 2 感染和冠状病毒病-19 的血液病理学。
Surg Pathol Clin. 2023 Jun;16(2):197-211. doi: 10.1016/j.path.2023.01.007. Epub 2023 Feb 2.
本文引用的文献
1
Mediastinal lymphadenopathy and prognosis of COVID-19 disease.纵隔淋巴结肿大与新型冠状病毒肺炎疾病的预后
Iran J Microbiol. 2021 Aug;13(4):495-501. doi: 10.18502/ijm.v13i4.6974.
2
Mediastinal lymphadenopathy may predict 30-day mortality in patients with COVID-19.纵隔淋巴结病可能预示 COVID-19 患者 30 天死亡率。
Clin Imaging. 2021 Jul;75:119-124. doi: 10.1016/j.clinimag.2021.01.028. Epub 2021 Feb 2.
3
Scoring systems for predicting mortality for severe patients with COVID-19.用于预测 COVID-19 重症患者死亡率的评分系统。
EClinicalMedicine. 2020 Jul 3;24:100426. doi: 10.1016/j.eclinm.2020.100426. eCollection 2020 Jul.
4
Association of mediastinal lymphadenopathy with COVID-19 prognosis.纵隔淋巴结肿大与新型冠状病毒肺炎预后的相关性
Lancet Infect Dis. 2020 Nov;20(11):1230-1231. doi: 10.1016/S1473-3099(20)30521-1. Epub 2020 Jun 19.
5
A brief-review of the risk factors for covid-19 severity.Covid-19 严重程度的危险因素简述。
Rev Saude Publica. 2020;54:60. doi: 10.11606/s1518-8787.2020054002481. Epub 2020 Jun 1.
6
Mediastinal lymphadenopathy in patients with severe COVID-19.重症新型冠状病毒肺炎患者的纵隔淋巴结肿大
Lancet Infect Dis. 2020 Nov;20(11):1230. doi: 10.1016/S1473-3099(20)30310-8. Epub 2020 Apr 21.
7
Coronavirus Disease 2019 (COVID-19) CT Findings: A Systematic Review and Meta-analysis.新型冠状病毒病 2019（COVID-19）的 CT 表现：系统评价和荟萃分析。
J Am Coll Radiol. 2020 Jun;17(6):701-709. doi: 10.1016/j.jacr.2020.03.006. Epub 2020 Mar 25.
8
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal.COVID-19 诊断和预后预测模型：系统评价和批判性评估。
BMJ. 2020 Apr 7;369:m1328. doi: 10.1136/bmj.m1328.
9
Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients.新型冠状病毒病 2019（COVID-19）：919 例患者影像学表现的系统评价。
AJR Am J Roentgenol. 2020 Jul;215(1):87-93. doi: 10.2214/AJR.20.23034. Epub 2020 Mar 14.
10
Managing Incidental Findings on Thoracic CT: Mediastinal and Cardiovascular Findings. A White Paper of the ACR Incidental Findings Committee.管理胸部 CT 的偶然发现：纵隔和心血管发现。ACR 偶然发现委员会白皮书。
J Am Coll Radiol. 2018 Aug;15(8):1087-1096. doi: 10.1016/j.jacr.2018.04.029. Epub 2018 Jun 22.
Zotero 插件